Home » Newsletters » BioWorld Science

BioWorld Science

March 8, 2016

View Archived Issues

Lilly presents efficacy and safety analyses of ixekizumab for moderate-to-severe psoriasis

Novel model systems developed for adenoid cystic carcinoma of the salivary gland

Biofrontera presents full phase III results of BF-200 ALA for the treatment of BCC

Novel antifungal compound VL-2397 enters phase I trials

Cancer Genetics launches next-generation sequencing panel for solid tumors

Dana-Farber Cancer Institute and University of Pennsylvania disclose HIV entry inhibitors

Corbus to study Resunab for systemic lupus erythematosus

d-Methadone safe and well tolerated in phase I chronic pain trial

Summit Therapeutics reports microbiome data from phase II trial of ridinilazole

Enrollment opens in phase I study of ISC-hpNSC for Parkinson's disease

Celldex to discontinue phase III study of Rintega following DSMB recommendation

Serum VEGF shows promise as a prognostic marker for pemphigus foliaceus

Efficacy of CCR4 antagonist from AstraZeneca tested in canine model of atopic dermatitis

Xencor initiates phase II trials of XmAb-5871 for IgG4-related disease and SLE

Update on progress of SORAMIC liver cancer study

Cempra to receive funding for phase II/III trial of solithromycin in pediatric patients with CABP

AbbVie and Boehringer Ingelheim enter global collaboration on immunology compounds

KemPharm files IND for KP-511

One-year data from phase III trial of Cx-601 for complex perianal fistulas in Crohn's disease

Plexxikon initiates phase Ib study of PLX-51107 in advanced malignancies

ITM raises funding to advance development of radiopharmaceutical products

Companies update initiatives in light of Zika virus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...